Oisin Biotechnologies Company
Founded in 2014 in Seattle, Washington, Oisin develops DNA-directed gene therapies designed to selectively eliminate senescent or diseased cells. Its lead platform uses Suicide Gene Therapy™, which employs inducible promoters to activate cell-killing genes only in harmful cells. The company aims to rejuvenate tissues by reducing chronic inflammation and cellular dysfunction. (oisinbio.com)
Number Of Exists:
11-50
Headquarters:
800 5th Avenue, Suite 4100, Seattle, WA 98104, United States
Employee Number:
17
Estimated Revenue:
No public info
Founded Date:
2014